Dosidal · Switzerland

Trileptal 60 mg/ml, Suspension zum Einnehmen

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:52852 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 52852
atc: N03AF02
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 1997-08-20
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: N03AF02
authorisation_number: 52852
form: SUOR
holder: Novartis Pharma Schweiz AG
holder_partner_nr: 1006575
it_number: 01.07.1.
name: Trileptal 60 mg/ml, Suspension zum Einnehmen
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
ofFmYJqeP-ed9wCRR9XXyVwlELjvbgluCQnDuAW9m2IIQXG9p2SAuGPTuIbqmAnPaE9uU_8jo9nLv51VhlTL4g
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:52852 · Related records in other markets · Dosidal